Related Experiment Videos
Rituximab-induced vasculitis: A case report and review of the medical published work
Min Joo Kim1, Hyung Ok Kim, Ho Yeon Kim
1Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea.
Abstract:
Rituximab is an anti-CD20 chimeric murine/human monoclonal antibody mainly used in the treatment of patients with a cutaneous lymphoid malignancy. Among the side-effects associated with rituximab administration, vasculitis has been rarely reported. There are two reported cases in the English language medical published work. We describe a 38-year-old Korean man with cutaneous vasculitis occurring 1 day after rituximab administration.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Myocarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease IV: Nursing Management